Amgen Inc (HKSE:04332)
HK$ 1761 0 (0%) Market Cap: 1.17 Til Enterprise Value: 1.57 Til PE Ratio: 35.86 PB Ratio: 20.00 GF Score: 92/100

Amgen Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Dec 01, 2020 / 06:50PM GMT
Release Date Price: HK$1850
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Fantastic. Listen, thank you guys for joining us. I think it's become a bit of a custom now hosting Amgen Management on our conference. Pleasure to have the whole team. We have David from the R&D side. We have Peter from the finance office. We have Arvind from the Investor Relations and the finance office. So really great to see everyone.

Arvind, I'll turn it over to you for some opening comments. And at the end of the opening comments, Arvind, can you also tell us how many books are behind David?

Arvind Sood
Amgen Inc. - VP of IR

Well, let me actually start off with that. I think he's got about 80 books back there. And he has read all of them.

Umer Raffat;David M. Reese
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research;Amgen Inc. - EVP of Research &

Okay. No, he's wearing all of them.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot